Feb 28 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* Mithra concludes exclusive license and supply agreement with Mayne Pharma MYX.AX for myring marketing in the United States
* Under the terms of the agreement, Mayne Pharma will pay milestones of at least 10 million euros ($10.59 million) following approval by US (FDA)
* Mithra will produce Myring for Mayne Pharma in its Research, Development and Production Center (Mithra CDMO)
* Under the terms of the agreement, Mithra will receive 2.4 million euros upon signing Source text for Eikon: ID:nNDL4sRLsd Further company coverage: MITRA.BR ($1 = 0.9446 euros) (Gdynia Newsroom)